Mortality from epilepsy: results from a prospective population-based study

Patients with epilepsy may be subject to an increased risk of premature death from the underlying cause, or from the epilepsy itself. The extent and nature of this risk has been insufficiently investigated. Standard mortality ratios (SMRs) of patients with newly diagnosed epilepsy were determined in a prospective national population-based study. 1091 patients with newly diagnosed or suspected epilepsy were ascertained who were attending one of 275 UK general practices from 1984-1987. 1091 patients were classified after 6 months as definite epilepsy (564), possible epilepsy (228), febrile seizures (220), or not epilepsy (79). Over a median follow up of 6.9 years the SMR for patients with definite or possible epilepsy was 2.5 (95% CI 2.1-2.9), and 3.0 (2.5-3.7) for definite epilepsy. The SMR was highest during the first year after diagnosis 5.1 (3.8-6.5), declined to 2.5 (1.5-3.9) at 3 years, and 1.3 (0.7-2.0) at 5 years. The commonest causes of death were pneumonia (SMR 7.2), cancer (3.5), and stroke (3.7). The SMR for patients with idiopathic epilepsy was 1.6 (1.0-2.4), remote symptomatic epilepsy 4.3 (3.3-5.5), and acute symptomatic epilepsy 2.9 (1.7-4.5). Mortality in patients with newly-diagnosed epilepsy was high, mainly due to the underlying cause. The SMR for idiopathic epilepsy was also raised, suggesting that epilepsy per se may carry a small risk of death.

[1]  T. B. Cole,et al.  Sudden unexplained death in young persons with primary epilepsy , 1992 .

[2]  Y. M. Hart,et al.  National General Practice Study of Epilepsy: recurrence after a first seizure , 1990, The Lancet.

[3]  Josemir W Sander,et al.  Mortality in patients with epilepsy: a study of patients in long term residential care. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[4]  E. D. Schwade,et al.  MORTALITY IN EPILEPSY , 1954 .

[5]  B. Barraclough.  The suicide rate of epilepsy , 1987, Acta psychiatrica Scandinavica.

[6]  W. Hauser,et al.  Ischemic Heart Disease in Patients with Epilepsy , 1976, Epilepsia.

[7]  M. Moore.  Pulmonary changes in hydantoin therapy. , 1959, Journal of the American Medical Association.

[8]  J. Jancar.  ANTICONVULSANT DRUGS AND CANCER , 1980, The Lancet.

[9]  W. Hauser,et al.  Heart Disease Mortality and Morbidity in Patients with Epilepsy , 1984, Epilepsia.

[10]  M. Kaste,et al.  Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study. , 1985, British medical journal.

[11]  S. White,et al.  ANTICONVULSANT DRUGS AND CANCER A Cohort Study in Patients with Severe Epilepsy , 1979, The Lancet.

[12]  Janusz J. Zielihski.  Epilepsy and Mortality Rate and Cause of Death , 1974 .

[13]  W. Hauser,et al.  Mortality in Patients with Epilepsy , 1980, Epilepsia.

[14]  Massey Ew,et al.  Mortality from Epilepsy , 1985 .

[15]  Josemir W Sander,et al.  National General Practice Study of Epilepsy and Epileptic Seizures: Objectives and Study Methodology of the Largest Reported Prospective Cohort Study of Epilepsy , 1989, Neuroepidemiology.